Ex-Cel­gene CEO Bob Hug­in makes a leap back in­to biotech, join­ing an em­bat­tled Al­ler­gan's board

Bob Hug­in is back.

The for­mer Cel­gene CEO, who stepped down from the top job when the big biotech’s shares and rep were rid­ing high in the sad­dle, is jump­ing on­to the board at Al­ler­gan $AGN — which is slow­ly thaw­ing to the idea of re­vamp­ing its lead­er­ship struc­ture.

Un­der pres­sure from the hedge fund Ap­paloosa LP to di­vide the role of chair­man and CEO, Al­ler­gan’s board and CEO Brent Saun­ders used the news of Hug­in’s ar­rival on the board to note that the com­pa­ny will do that — even­tu­al­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER